Grove, R A <br/><br/>
Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis.  [electronic resource] 

 -  European journal of neurology  Jul 2013 
 - 1032-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-1331 
<br/><br/><label>Standard No.: </label>10.1111/ene.12097  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Female<br/>Humans<br/>Integrin alpha4beta1--antagonists & inhibitors<br/>Integrins--antagonists & inhibitors<br/>Leukocyte Count<br/>Lymphocyte Count<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--blood<br/>Treatment Outcome